Indonesia Advances mRNA-Based Dengue Vaccine Development
Indonesian research institutions and companies are collaborating to develop an mRNA-based vaccine targeting all four dengue virus serotypes. Building a supportive ecosystem for commercializing research findings is a key challenge.
This article requires PRO
This article is outside the free access window or is a special report. PRO unlocks it and the full archive.
Related articles
- Prabowo Invites Students from New University to Presidential Palace
Indonesian President Prabowo Subianto invited students from the newly established Universitas Republik Indonesia (URI), an institution he helped found, to the Presidential Palace for a session on a future leaders program. This move signals an effort to cultivate young elites for strategic national initiatives.
- Jakarta to Launch Overseas Scholarship Program in 2027
The Jakarta provincial government will launch the 'LPDP Jakarta' scholarship program in 2027, aiming to send approximately 75 students abroad initially. The program seeks to cultivate future leaders for Jakarta.
- Jayamas Medica Reports 26.1% Sales Growth in Q3 2026, Highlighting Strong Medical Device Demand
Indonesian medical device manufacturer Jayamas Medica (OMED) reported a 26.1% year-on-year increase in net sales to IDR 1.85 trillion for the first nine months of 2026, indicating sustained demand for medical equipment, particularly consumables.
- Jakarta Appoints Student 'Anti-Hoax Ambassadors' to Combat Misinformation in Schools
The Jakarta Provincial Government, in collaboration with the Ministry of Communication and Digital, has launched a program appointing students as 'Anti-Hoax Ambassadors' to bolster efforts against misinformation in schools. This initiative recognizes the crucial role of youth in information dissemination and aims to foster critical thinking skills.